10.39
2.26%
-0.24
Pre-market:
10.39
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Viatris Inc stock is currently priced at $10.39, with a 24-hour trading volume of 7.76M.
It has seen a -2.26% decreased in the last 24 hours and a -8.54% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $10.70 pivot point. If it approaches the $10.28 support level, significant changes may occur.
Previous Close:
$10.63
Open:
$10.49
24h Volume:
7.76M
Market Cap:
$12.37B
Revenue:
$15.36B
Net Income/Loss:
$-56.10M
P/E Ratio:
6.7908
EPS:
1.53
Net Cash Flow:
$2.00B
1W Performance:
-0.29%
1M Performance:
-8.54%
6M Performance:
+2.57%
1Y Performance:
+7.89%
Viatris Inc Stock (VTRS) Company Profile
Name
Viatris Inc
Sector
Phone
724 514 1968
Address
1000 Mylan Boulevard, Canonsburg
Viatris Inc Stock (VTRS) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-23-23 | Downgrade | BofA Securities | Neutral → Underperform |
Jun-23-23 | Downgrade | Barclays | Equal Weight → Underweight |
Apr-24-23 | Downgrade | Barclays | Overweight → Equal Weight |
Feb-17-23 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
Jan-27-23 | Upgrade | Jefferies | Hold → Buy |
Nov-10-22 | Upgrade | UBS | Sell → Neutral |
Nov-08-22 | Upgrade | Piper Sandler | Underweight → Neutral |
Oct-21-22 | Resumed | Jefferies | Hold |
Jun-14-22 | Initiated | UBS | Sell |
May-10-22 | Downgrade | Piper Sandler | Neutral → Underweight |
Mar-01-22 | Downgrade | BofA Securities | Buy → Neutral |
Mar-01-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
Jun-15-21 | Initiated | Citigroup | Neutral |
Apr-07-21 | Resumed | RBC Capital Mkts | Outperform |
Mar-08-21 | Downgrade | Goldman | Buy → Neutral |
Mar-02-21 | Downgrade | JP Morgan | Overweight → Neutral |
Feb-26-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
Jan-05-21 | Initiated | Argus | Hold |
Dec-14-20 | Initiated | Bernstein | Mkt Perform |
View All
Viatris Inc Stock (VTRS) Latest News
It is Poised to be a Bull Market for Viatris Inc (VTRS) – Sete News - SETE News
SETE News
Viatris Inc (VTRS) is an excellent investment, but the stock is overvalued/undervalued right now – US Post News - US Post News
US Post News
Viatris Inc Inc. (VTRS) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
The InvestChronicle
Viatris Inc [NASDAQ: VTRS] Sees Decrease in Stock Value – Knox Daily - Knox Daily
Knox Daily
Viatris Inc. (VTRS) Presents at Jefferies 2024 Global Healthcare Conference (Transcript) - Seeking Alpha
Seeking Alpha
Stock Performance Spotlight: Viatris Inc (VTRS) Ends the Day at 10.49, Down by -0.38 – DWinneX - The Dwinnex
The Dwinnex
Viatris Inc Stock (VTRS) Financials Data
Viatris Inc (VTRS) Revenue 2024
VTRS reported a revenue (TTM) of $15.36 billion for the quarter ending March 31, 2024, a -2.78% decline year-over-year.
Viatris Inc (VTRS) Net Income 2024
VTRS net income (TTM) was -$56.10 million for the quarter ending March 31, 2024, a -102.95% decrease year-over-year.
Viatris Inc (VTRS) Cash Flow 2024
VTRS recorded a free cash flow (TTM) of $2.00 billion for the quarter ending March 31, 2024, a -14.22% decrease year-over-year.
Viatris Inc (VTRS) Earnings per Share 2024
VTRS earnings per share (TTM) was -$0.06 for the quarter ending March 31, 2024, a -103.82% decline year-over-year.
About Viatris Inc
Viatris Inc., a healthcare company, manufactures and distributes various medicines for patients in the United States and internationally. Its portfolio comprises approximately 1,400 approved molecules across a range of therapeutic areas, including non-communicable and infectious diseases; complex generic and branded medicines; a portfolio of biosimilars; and various over-the-counter consumer products, as well as active pharmaceutical ingredients. The company is headquartered in Canonsburg, Pennsylvania.
Cap:
|
Volume (24h):